JP2001064145A - Composition for external use - Google Patents

Composition for external use

Info

Publication number
JP2001064145A
JP2001064145A JP23797199A JP23797199A JP2001064145A JP 2001064145 A JP2001064145 A JP 2001064145A JP 23797199 A JP23797199 A JP 23797199A JP 23797199 A JP23797199 A JP 23797199A JP 2001064145 A JP2001064145 A JP 2001064145A
Authority
JP
Japan
Prior art keywords
composition
extract
plant
genus
plants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP23797199A
Other languages
Japanese (ja)
Inventor
Hiroyuki Shimizu
裕之 清水
Chiyoko Uchiyama
千代子 内山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP23797199A priority Critical patent/JP2001064145A/en
Publication of JP2001064145A publication Critical patent/JP2001064145A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a composition for external use applicable to various fields such as medicines, quasi-drugs and cosmetics and having high safety and further protecting actions on biotissues against injury and activating actions on the biotissues. SOLUTION: This composition for external use contains one or more species of plants selected from the group consisting of plants of the genera Xylopia, Caryocar, Guazuma, Cuphea, Heteropteris, Sciadotenia, Ampelozizyphus, Luehea, Juglans and Lippia or extracts thereof. The composition for external use is stable and excellent in prophylactic or ameliorating effects on biological hypofunction caused by environmental stress or aging, especially hypofunction of skin, hair and tissues in an oral cavity. Thereby, the composition has an extremely wide application range.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、環境ストレスや加
齢によって引き起こされる生体機能の低下、特に皮膚・
毛髪・口腔組織の機能の低下を予防あるいは改善する効
果の高い外用組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the reduction of biological functions caused by environmental stress and aging,
The present invention relates to a composition for external use having a high effect of preventing or improving the function of hair and oral tissues.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】通常、
皮膚・毛髪・口腔などの生体組織は、新陳代謝によっ
て、種々の要因によって起こる機能の低下や構造的変化
などを速やかに改善することができる。しかしながら、
紫外線や乾燥・有害化学物質などの過度な暴露や加齢に
伴って、生体組織に傷害が蓄積することにより、本来の
働きが損なわれ、さまざまなトラブルが発生する。皮膚
であれば、しみやしわ、肌荒れ、アトピー様症状などに
悩まされるようになる。毛髪においては、抜け毛、薄
毛、白髪などの発生を引き起こす。口腔分野では、歯肉
の退縮や歯茎からの出血といった病態を示すようにな
る。このように機能的、構造的な劣化を示す生体組織に
対して、機能低下の原因となる活性酸素種の発生や慢性
的炎症を防いだり、組織自体を賦活化して機能の低下し
た生体組織を修復し、健常組織へと再生する方法が考え
らている。
BACKGROUND OF THE INVENTION Generally,
BACKGROUND ART Biological tissues such as skin, hair, and oral cavity can rapidly improve functional deterioration and structural changes caused by various factors due to metabolism. However,
Injuries accumulate in living tissues due to excessive exposure to aging, such as ultraviolet rays, dryness and harmful chemical substances, thereby impairing the original function and causing various troubles. Skin suffers from spots, wrinkles, rough skin, and atopic symptoms. In hair, it causes hair loss, thin hair, gray hair, and the like. In the oral field, they show pathological conditions such as gingival regression and bleeding from the gums. In this way, for living tissues that show functional and structural deterioration, the generation of reactive oxygen species and the chronic inflammation that cause functional deterioration are prevented, and living tissues with reduced functions are activated by reactivating the tissues themselves. A method of repairing and regenerating to healthy tissue is being considered.

【0003】活性酸素種の発生を防ぐものとしては、生
体組織にダメージを与える活性酸素種の一つである一重
項酸素を消去するものとしてビタミン類や各種植物抽出
物が提案されている(特開平7−133216号公
報)。また、慢性的な炎症やアレルギー反応を抑えるも
のとしては、ヒアルロニダーゼ阻害活性を有する物質の
探索が盛んに行われており、いくつかの海藻や植物成分
が見出されている(特開平8−53360号公報)。組
織自体を賦活化する手段としては、皮膚組織や歯肉組織
のコラーゲン合成能を高める方法が数多く示されおり、
細菌や植物の抽出物、アミノ酸組成物を用いる方法(特
開平7−194375号公報)などが提案されている。
[0003] In order to prevent the generation of reactive oxygen species, vitamins and various plant extracts have been proposed to eliminate singlet oxygen, which is one of the reactive oxygen species that damages living tissues. JP-A-7-133216). Further, as a substance for suppressing chronic inflammation and allergic reaction, a substance having a hyaluronidase inhibitory activity has been actively searched for, and some seaweeds and plant components have been found (JP-A-8-53360). No.). As a means to activate the tissue itself, many methods have been shown to increase the collagen synthesis ability of skin tissue and gingival tissue,
A method using an extract of a bacterium or a plant, or an amino acid composition (Japanese Patent Application Laid-Open No. 7-194375) has been proposed.

【0004】しかしいずれの手段も、安全性上使用量の
制限が必要であったり、作用・効果が不十分な点や、活
性を保ったまま製剤に安定に配合することが困難である
というような問題点が残されていた。
[0004] However, it seems that all of these methods require the use of a limited amount in terms of safety, are insufficient in action and effect, and are difficult to stably compound in a preparation while maintaining the activity. Problems remain.

【0005】本発明は、上記事情に鑑みなされたもの
で、医薬品、医薬部外品、化粧品など様々な分野に適用
でき、安全性が高く、かつ生体組織に対する優れた傷害
防御作用ならびに賦活作用を有する外用組成物を提供す
ることを目的とする。
The present invention has been made in view of the above circumstances, and can be applied to various fields such as pharmaceuticals, quasi-drugs, and cosmetics, has high safety, and has an excellent injury protection action and activation action for living tissues. It is intended to provide a composition for external use having the same.

【0006】[0006]

【課題を解決するための手段及び発明の実施の形態】本
発明者らは、天然物の生体組織に対する優れた傷害防御
作用ならびに賦活作用について鋭意研究を重ねた結果、
キシロピア(Xylopia)属植物、バターナットノ
キ(Caryocar)属植物、グアズマ(Guazu
ma)属植物、タバコソウ(Cuphea)属植物、ヘ
テロプテリス(Heteropteris)属植物、ス
キアドテニア(Sciadotenia)属植物、アン
ペロジジフス(Ampelozizyphus)属植
物、ルエヘア(Luehea)属植物、クルミ(Jug
lans)属植物、イワダレソウ(Lippia)属植
物又はそれらの抽出物に優れた生体組織に対する傷害防
御作用ならびに賦活作用があることを見出し、本発明を
完成するに至った。
Means for Solving the Problems and Embodiments of the Invention The present inventors have conducted intensive studies on the excellent injury protective action and activation action of natural products on living tissues.
Xylopia genus plant, Butternut tree (Caryocar) genus plant, Guazuma (Guazu)
ma) genus plant, Cuphea genus plant, Heteropteris genus plant, Sciadotenia genus plant, Ampelodizifusus genus plant, Luhea genus plant, Walnut (Jug)
It has been found that a plant belonging to the genus lans, a plant belonging to the genus Lippia, or an extract thereof has an excellent injury-protecting effect and an activating effect on living tissue, and the present invention has been completed.

【0007】従って、本発明は、上記植物又はそれらの
抽出物の一種又は二種以上を含有する外用組成物を提供
する。本発明の外用組成物は、皮膚・毛髪組織、口腔組
織に対して優れた傷害防御作用ならびに賦活作用を有
し、かつ安全性が高く、医薬品、医薬部外品、化粧品な
どに好適に用いることができる。
Accordingly, the present invention provides an external composition containing one or more of the above-mentioned plants or their extracts. The composition for external use of the present invention has an excellent injury-protecting action and an activating action on skin / hair tissue and oral tissues, and has high safety, and is suitably used for pharmaceuticals, quasi-drugs, cosmetics, and the like. Can be.

【0008】以下、本発明につき更に詳しく説明する。
本発明に用いられる、キシロピア(Xylopia)属
植物は、熱帯アメリカで調味料、駆風剤、健胃剤などと
して用いられており、中でも現地名インビエイロ:Im
bieiro(Xylopia benthami
i)、ピンダイーバ・デ・フォーリャ・ペケーナ:Pi
ndaiba−de−folha−pequena
(X.brasiliensis)、ピンダイーバ・ヴ
ェルメーリャ:Pindaiba−vermelha
(X.carminativa)、コアジェルクー:C
oagerucu(X.frutescens)に優れ
た作用があり、特に望ましい。バターナットノキ(Ca
ryocar)属植物は、熱帯中南米で収斂、気管支の
病気、下痢止めなどの用途で用いられており、中でも現
地名ピキー:Piqui(Caryocar bras
iliense)、ピキアー:Piquia(C.co
riaceum)、ピキアラーナ・ダ・テラ・フィル
メ:Piquiarana−da−terra−fir
me(C.glabrum)、ピキアー・ヴェルダデイ
ロ:Piquia−verdadeiro(C.vil
losum)に優れた作用があり、特に望ましい。グア
ズマ(Guazuma)属植物は、熱帯アメリカで煎剤
として梅毒、肝臓病、皮膚病、傷薬に用いる。樹皮のシ
ロップは呼吸器病に用い、咳止め、喘息、肺炎などに用
いられており、中でも現地名ムタンバ:Mutamba
(Guazuma ulmifolia)に優れた効果
があり、特に望ましい。タバコソウ(Cuphea)属
植物は、熱帯アメリカで主に茶剤として、浄血作用があ
り、解熱、発汗、利尿などに用いられている。中でも現
地名セッテ・サングリアス:Sete−sangria
s(Cuphea antisyphilitic
a)、バルサモナ:Balsamona(C.cart
hagenensis)、モタ・カナ:Mata−ca
na(C.ingrata)に優れた効果があり、特に
望ましい。ヘテロプテリス(Heteropteri
s)属植物は、南アメリカで茶剤、又は煎剤として強
壮、催淫などに用いられおり、中でも現地名ノー・デ・
カショーロ:No−de−cachorro(Hete
ropteris aphrodisiaca)、ムラ
プアマ:Marapuama(H.campestri
s)、ポアイア・ミネイラ:Poaia−mineir
a(H.pragua)、サラバツクー:Saraba
tucu(H.suberosa)、プラグアー:Pr
agua(H.syrungiforia)に優れた効
果があり、特に望ましい。スキアドテニア(Sciad
otenia)属植物は、ブラジルで茶剤として強壮、
興奮剤に用いられ、中でも現地名シポー・アマルゴー
ゾ:Cipo−amargoso(Sciadoten
ia candicans)、アブータ:Abuta
(S.paraensis)、に優れた効果があり、特
に望ましい。アンペロジジフス(Ampelozizy
phus)属植物はブラジルで強壮、解熱、傷薬として
用いられており、中でも現地名サラクーラ・ムイラー:
Saracura−muira(Ampelozizy
phus amazonicus)に優れた効果があ
り、特に望ましい。ルエヘア(Luehea)属植物
は、南アメリカで皮は関節炎、リューマチに用い、葉と
花は茶剤又は煎剤として、収斂、血止めに用いられてお
り、中でもアソイタ・カバーロ:Acoita−cav
alo(Luehea divaricata)、イヴ
ィチンガ:Ivintinga(L.grandifl
ora)に優れた効果があり、特に望ましい。クルミ
(Juglans)属植物は、アジア、南北アメリカで
食用に用いられており、中でも南アメリカの現地名ノゲ
イラ:Nogueira(Juglans regi
a)に優れた効果があり、特に望ましい。イワダレソウ
(Lippia)属植物は、熱帯アメリカで芳香、鎮
静、消毒、リューマチなどに用いられ、中でも現地名エ
ルヴァ・シドレイラ:Erva−cidreira(L
ippia alba)、アレクリン・ピメンタ:Al
ecrim−pimenta(L.alnifoli
a)、アレクリン・ダ・チャパダ:Alecrim−d
a−chapada(L.gracilis)、アレク
リン・ド・カンポ:Alecrim−do−campo
(L.microphylla)、カピトン・ド・マッ
ト:Capitao−do−mato(L.pseud
o−thea)、エストレパ・カヴァロ:Estrep
a−cavalo(L.sidoides)に優れた効
果があり、望ましい。
Hereinafter, the present invention will be described in more detail.
The plant of the genus Xylopia used in the present invention is used as a seasoning, carminative, stomachic, etc. in tropical America, and among them, the local name Invieiro: Im
biero (Xylopia benthami)
i), Pindiva de Folia Pequena: Pi
ndaiba-de-folha-pequena
(X. brasiliensis), Pindiva-Vermelha: Pindaiba-vermelha
(X. carminative), core gel coo: C
Oagerucu (X. flutescens) has an excellent action and is particularly desirable. Butternut tree (Ca
Ryocar) plants are used in tropical and Central and South America for purposes such as astringency, bronchial disease, and diarrhea control. Among them, the local name Piqui (Caryocar brass) is used.
liense), Pichia: Piqia (C.co.)
riaceum), Pichiarana-da-terra-fir
me (C. glabrum), Pichia-Verdadeiro (P.
losum) has an excellent action and is particularly desirable. Guazuma genus plants are used as decoctions in tropical America for syphilis, liver disease, skin disease and wound medicine. The bark syrup is used for respiratory diseases, cough, asthma, pneumonia, etc., and among them, the local name Mutamba: Mutamba
(Guazuma ulmifolia) has an excellent effect, and is particularly desirable. BACKGROUND ART Plants of the genus Cuphea have a blood purifying action mainly as a tea agent in tropical America, and are used for antipyresis, sweating, diuresis, and the like. Among them, the local name Sete-Sangrias: Sete-sangria
s (Cuphe antisyphilitic
a), Balsamona: Balsamona (C. cart
hagenensis), Mota Cana: Meta-ca
na (C. ingrata) has an excellent effect, and is particularly desirable. Heteropteris
s) The genus plant is used as a tea or decoction for tonicity, aphrodisiac, etc. in South America.
Cashilo: No-de-cacharo (Heté
ropteris aphrodisiaa), Marapuama: H. campestri
s), Poia-mineir
a (H. pragua), Sarabatsk: Saraba
tucu (H.suberosa), pluger: Pr
agua (H. syrungiforia) has an excellent effect and is particularly desirable. Skiadtenia
otenia) plants are tonic as a tea in Brazil,
It is used as a stimulant and, among others, the local name Sipo-amargoso (Sciadoten)
ia candicans), Abuta: Abuta
(S. paraensis), which is particularly desirable. Ampelodizys
Phus) plants are used in Brazil as tonic, antipyretic and anti-inflammation agents, with the local name Sarakula Muiler:
Saracura-muira (Amperozizy
phas amazonicus has an excellent effect and is particularly desirable. Luheea plants are used in South America for arthritis and rheumatism in the skin, and leaves and flowers are used as a tea or decoction for astringency and blood stasis. Among them, Asoita-cabaro:
alo (Luehea divaricata), Ivitinga: Ivintinga (L. grandifl)
ora) has an excellent effect and is particularly desirable. The walnut (Juglans) genus plant is used for food in Asia and North and South America, and in particular, the local name Nogueira (Juglans regi) in South America.
a) has an excellent effect and is particularly desirable. Plants belonging to the genus Lippia are used in tropical America for aroma, sedation, disinfection, rheumatism, etc., and among them, the local name Erva-cidreira (L)
ipia alba), Alecrin Pimenta: Al
ecrim-pimenta (L. alnifoli
a), Alecrim-d-Chappada: Alecrim-d
a-chapada (L. gracilis), Alecrim-do-campo: Alecrim-do-campo
(L. microphylla), Capitón de mat: Capitao-do-mat (L. pseudo
o-thea), Estrepa Cavallo: Estrep
It has an excellent effect on a-cavalo (L. sideoids) and is desirable.

【0009】上記植物群は、その木部、心材部、樹皮
部、茎部、枝部、葉部、根部、種子部、果実部、花部な
どを用いることができる。
As the above-mentioned plant group, xylem, heartwood, bark, stem, branch, leaf, root, seed, fruit, flower and the like can be used.

【0010】上記植物の抽出物としては、抽出エキスで
もよく、抽出液から分離精製したものでもよい。抽出エ
キスの場合は、上記植物体を乾燥あるいはそのまま粉砕
したものを溶媒抽出することによって得ることができ、
抽出溶媒が使用上無毒性のものであれば抽出液をそのま
ま用いても、適宜な溶媒で希釈した希釈液として用いて
もよく、あるいは濃縮エキスとしたり、凍結乾燥などに
より乾燥粉末としたり、ペースト状に調製したものなど
が利用できる。
[0010] The plant extract may be an extract extract or a product separated and purified from the extract. In the case of an extract extract, the plant can be obtained by solvent extraction of a dried or crushed plant,
If the extraction solvent is non-toxic for use, the extract may be used as it is, or may be used as a diluent diluted with an appropriate solvent, or as a concentrated extract, or as a dry powder by freeze-drying, or paste. And the like prepared in a state can be used.

【0011】上記植物の抽出物を得るのに用いる溶媒と
しては、メタノール、エタノール、ブタノール、ヘキサ
ン、ヘプタン、シクロヘキサン、酢酸エチル、アセトン
などの一般に用いられる有機溶媒、及び水などを挙げる
ことができ、これらの一種を単独で又は二種以上を混合
して使用することができる。これらの溶媒の中では特に
メタノール、エタノール、水が好ましい。なお、抽出処
理は、通常3〜70℃程度の温度で常法によって行うこ
とができる。
Examples of the solvent used to obtain the above plant extract include commonly used organic solvents such as methanol, ethanol, butanol, hexane, heptane, cyclohexane, ethyl acetate, acetone and the like, and water. One of these can be used alone, or two or more can be used as a mixture. Among these solvents, methanol, ethanol and water are particularly preferred. In addition, the extraction treatment can be performed by a conventional method at a temperature of usually about 3 to 70 ° C.

【0012】溶媒抽出の他に、炭酸ガスを超臨界状態に
して行う超臨界抽出によって得たエキスも同様に利用で
きる。このときには、抽出助剤としてヘキサン、エタノ
ールなどを用いることもできる。また、抽出物からの有
効成分の分離精製は、抽出物をカラムクロマトグラフィ
ー、液体クロマトグラフィーなどで精製することによっ
て行うことができる。
In addition to the solvent extraction, an extract obtained by supercritical extraction in which carbon dioxide is brought into a supercritical state can be similarly used. At this time, hexane, ethanol, or the like can be used as an extraction aid. Separation and purification of the active ingredient from the extract can be performed by purifying the extract by column chromatography, liquid chromatography, or the like.

【0013】本発明の外用組成物は、上記植物又はそれ
らの抽出物の一種又は二種以上を有効成分として含有す
るものである。その配合量は、有効量であり、組成物の
用途、剤型等に応じて適宜選定されるが、通常、0.0
0001〜20重量%配合するのがよい。好ましくは
0.0001〜10重量%配合するのがよい。配合量が
0.00001重量%未満であると、本発明の効果を発
揮できず、また剤型によっては製造が困難になるものも
あることから、20重量%を超えないほうがよい。
The composition for external use of the present invention contains one or more of the above plants or extracts thereof as an active ingredient. The compounding amount is an effective amount and is appropriately selected depending on the use of the composition, the dosage form, and the like.
It is preferred to mix 0001 to 20% by weight. Preferably, the content is 0.0001 to 10% by weight. If the compounding amount is less than 0.00001% by weight, the effects of the present invention cannot be exerted, and production may become difficult depending on the dosage form. Therefore, it is better not to exceed 20% by weight.

【0014】本発明の外用組成物は、皮膚、口腔用等の
粘膜、毛髪などに適用され、例えば、クリーム、ハンド
クリーム、乳液、化粧水、ローション、石鹸、ハンドソ
ープ、ボディソープ、制汗剤、水虫薬、にきび治療剤、
手指消毒剤、美白剤、貼付剤等の皮膚外用剤乃至皮膚化
粧料、シャンプー、リンス、トニック、育毛剤等の毛髪
化粧料、歯磨、洗口剤、歯肉マッサージクリーム等の口
腔用組成物などとして調製することができる。
The composition for external use of the present invention is applied to skin, mucous membrane for oral cavity, hair, etc., for example, cream, hand cream, milky lotion, lotion, soap, hand soap, body soap, antiperspirant , Athlete's foot medicine, acne treatment,
As a skin external preparation such as a hand disinfectant, a whitening agent, a patch, or a skin cosmetic, a hair cosmetic such as a shampoo, a rinse, a tonic, a hair restorer, an oral composition such as a toothpaste, a mouthwash, and a gum massage cream. Can be prepared.

【0015】この場合、本発明の外用組成物は、上記外
用組成物の種類、剤型などに応じた公知の配合成分を用
いて常法により調製し得る。なお、本発明組成物には、
上記有効成分に加えて、一般に用いられている細胞賦活
剤、例えば、ホルモン類、ビタミン類、サポニンなどの
生薬抽出物、胎盤抽出物、植物レクチンなどをあわせて
用いることができる。
In this case, the composition for external use of the present invention can be prepared by a conventional method using known components according to the type, dosage form and the like of the composition for external use. Incidentally, the composition of the present invention,
In addition to the above-mentioned active ingredients, commonly used cell activators, for example, crude drug extracts such as hormones, vitamins and saponins, placenta extracts, plant lectins and the like can be used.

【0016】[0016]

【発明の効果】本発明の外用組成物は、安定で、環境ス
トレスや加齢によって引き起こされる生体機能の低下、
特に皮膚・毛髪・口腔組織の機能の低下を予防あるいは
改善する効果に優れていることから、応用範囲が極めて
広いものである。
The composition for external use of the present invention is stable and has a reduced biological function caused by environmental stress and aging.
In particular, it has an excellent effect of preventing or improving the function of skin, hair, and oral tissues, and thus has a very wide range of application.

【0017】[0017]

【実施例】以下、調製例、実験例、実施例を挙げて本発
明を具体的に説明するが、本発明は下記の例に制限され
るものではない。
EXAMPLES The present invention will be specifically described below with reference to Preparation Examples, Experimental Examples and Examples, but the present invention is not limited to the following Examples.

【0018】〔調製例1〕キシロピア(Xylopi
a)属植物の抽出 インビエイロ:Imbieiro(Xylopia b
enthamii)の果実の粉砕物1kgに10Lの7
0%エタノールを加え、2日間抽出した。抽出液を濾過
した後、エタノールを減圧留去して、抽出エキス102
gを得た。また、ピンダイーバ・デ・フォーリャ・ペケ
ーナ:Pindaiba−de−folha−pequ
ena(X.brasiliensis)、ピンダイー
バ・ヴェルメーリャ:Pindaiba−vermel
ha(X.carminativa)、コアジェルク
ー:Coagerucu(X.frutescens)
のそれぞれの果実の粉砕物1kgに10Lのメタノール
を加え、2日間抽出した。抽出液を濾過した後、メタノ
ールを減圧留去して、抽出エキスをそれぞれ96g、1
11g、106g得た。
[Preparation Example 1] Xylopia
a) Extraction of plants of the genus Plant Invieiro: Imbieiro (Xylopia b
enthamii) 10 kg of 7 kg of crushed fruit
0% ethanol was added and extracted for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure, and the extract 102
g was obtained. Also, Pindiva-de-folha-pequ
ena (X. brasiliensis), Pindiva Vermelha: Pindaiba-vermel
ha (X. carminative), Coagerucu: Xagefrutescens
10 L of methanol was added to 1 kg of each crushed fruit, and extracted for 2 days. After filtering the extract, methanol was distilled off under reduced pressure, and 96 g of each extract was extracted.
11 g and 106 g were obtained.

【0019】〔調製例2〕バターナットノキ(Cary
ocar)属植物の抽出 ピキー:Piqui(Caryocar brasil
iense)とピキアラーナ・ダ・テラ・フィルメ:P
iquiarana−da−terra−firme
(C.glabrum)の、それぞれ果実の粉砕物1k
gに10Lのメタノールを加え、室温で2日間抽出し
た。抽出液を濾過した後、メタノールを減圧留去して、
抽出エキス114gと101gを得た。また、ピキア
ー:Piquia(C.coriaceum)、ピキア
ー・ヴェルダデイロ:Piquia−verdadei
ro(C.villosum)のそれぞれの果実の粉砕
物1kgから超臨界抽出により、それぞれ123g、1
42gのエキスを得た。
[Preparation Example 2] Butternut tree (Cary)
ocar) Extraction of plants of the genus Pici: Piqui (Caryocar brasil)
iense) and Pichiarana da Terra Filme: P
equianana-da-terra-film
1k of each crushed fruit of (C. glabrum)
10 g of methanol was added to g, and the mixture was extracted at room temperature for 2 days. After filtering the extract, methanol was distilled off under reduced pressure.
114 g and 101 g of the extract were obtained. Also, Pichia: Piqia (C. coliaceum), Pichia Verdadeiro: Piqia-verdadei
ro (C. illussum) from each 1 kg of the crushed fruit, by supercritical extraction, 123 g, 1
42 g of extract were obtained.

【0020】〔調製例3〕グアズマ(Guazuma)
属植物の抽出 ムタンバ:Mutamba(Guazuma ulmi
folia)の樹皮及び葉の粉砕物1kgに10Lの9
5%エタノールを加え、室温で2日間抽出した。抽出液
を濾過した後、エタノールを減圧留去して、抽出エキス
95gを得た。
[Preparation Example 3] Guazuma
Extraction of genus plants Mutamba: Mutamba (Guazuma ulmi)
10 liters of 9 per kg of crushed bark and leaf of folia)
5% ethanol was added, and the mixture was extracted at room temperature for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure to obtain 95 g of an extract.

【0021】〔調製例4〕タバコソウ(Cuphea)
属植物の抽出 セッテ・サングリアス:Sete−sangrias
(Cuphea antisyphilitica)と
バルサモナ:Balsamona(C.carthag
enensis)とモタ・カナ:Mata−cana
(C.ingrata)の、それぞれ樹木、葉の粉砕物
1kgに10Lの95%エタノールを加え、室温で2日
間抽出した。抽出液を濾過した後、エタノールを減圧留
去して、抽出エキス102g、87g、96gを得た。
[Preparation Example 4] Tobacco Saw (Cuphea)
Extraction of genus plants Sete-sangrias: Sete-sangrias
(Cuphe antisyphilitica) and balsamona: Balsamona (C. carthag)
enensis) and Mota Cana: Meta-cana
10 L of 95% ethanol was added to 1 kg of the crushed tree and leaf of (C. ingrata), and extracted at room temperature for 2 days. After filtering the extract, ethanol was distilled off under reduced pressure to obtain 102 g, 87 g and 96 g of the extract.

【0022】〔調製例5〕ヘテロプテリス(Heter
opteris)属植物の抽出 ノー・デ・カショーロ:No−de−cachorro
(Heteropteris aphrodisiac
a)、ムラプアマ:Marapuama(H.camp
estris)、ポアイア・ミネイラ:Poaia−m
ineira(H.Pragua)、サラバツクー:S
arabatucu(H.suberosa)とプラグ
アー:Pragua(H.syrungiforia)
の、それぞれ根の粉砕物1kgに10Lの95%エタノ
ールを加え、室温で2日間抽出した。抽出液を濾過した
後、エタノールを減圧留去して、抽出エキス99g、1
10g、90g、75g、81gを得た。
[Preparation Example 5] Heteropteris (Heter
opteris) Extraction of plants of the genus No-de-cachoro
(Heteropteris aphrodisiac
a), Murapuama: Marapuama (H.camp)
estris), Poia Minera: Poia-m
ineira (H. Pragua), Sarabatsk: S
arabatucu (H.suberosa) and pluger: Pragua (H. syrungiforia)
, 10 L of 95% ethanol was added to 1 kg of the ground material, and the mixture was extracted at room temperature for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure, and 99 g of the extract was extracted.
10 g, 90 g, 75 g and 81 g were obtained.

【0023】〔調製例6〕スキアドテニア(Sciad
otenia)属植物の抽出 シポー・アマルゴーゾ:Cipo−amargoso
(Sciadotenia candicans)とア
ブータ:Abuta(S.paraensis)の、そ
れぞれ根及び茎の粉砕物1kgに10Lの70%エタノ
ールを加え、室温で2日間抽出した。抽出液を濾過した
後、エタノールを減圧留去して、抽出エキス108g、
132gを得た。
[Preparation Example 6] Sciad tenia (Sciad)
otenia) Extraction of plants of the genus Sipo-Amargoso: Cipo-amargoso
10 kg of 70% ethanol was added to 1 kg of the ground and stem pulps of (Siadotenia candicans) and Abuta: Abuta (S. paraensis), and extracted at room temperature for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure, and 108 g of extract was obtained.
132 g were obtained.

【0024】〔調製例7〕アンペロジジフス(Ampe
lozizyphus)属植物の抽出 サラクーラ・ムイラー:Saracura−muira
(Ampelozizyphus amazonicu
s)の、それぞれ根及び葉の粉砕物1kgに10Lの9
5%エタノールを加え、室温で2日間抽出した。抽出液
を濾過した後、エタノールを減圧留去して、抽出エキス
103g、80gを得た。
[Preparation Example 7] Amperodisifus (Ampe
Extraction of plants of the genus lozizyfus) Saracula-muira
(Ampelozizyphus amazonicu
s) of 10 l of 9 g of ground pulverized root and leaf
5% ethanol was added, and the mixture was extracted at room temperature for 2 days. After filtering the extract, ethanol was distilled off under reduced pressure to obtain 103 g and 80 g of the extract.

【0025】〔調製例8〕ルエヘア(Luehea)属
植物の抽出 アソイタ・カバーロ:Acoita−cavalo(L
uehea divaricata)とイヴィチンガ:
Ivintinga(L.grandiflora)の
それぞれ根及び葉の粉砕物1kgに10Lの95%エタ
ノールを加え、室温で2日間抽出した。抽出液を濾過し
た後、エタノールを減圧留去して、抽出エキス106
g、87gを得た。
[Preparation Example 8] Extraction of plants belonging to the genus Luhea Asoita-cavalo (L
uehea divaricata) and Ivitinga:
10 L of 95% ethanol was added to 1 kg of each crushed root and leaf of Ivintinga (L. grandiflora) and extracted at room temperature for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure to obtain an extract 106.
g and 87 g were obtained.

【0026】〔調製例9〕クルミ(Juglans)属
植物の抽出 ノゲイラ:Nogueira(Juglans reg
ia)の樹皮の粉砕物1kgを超臨界抽出して、抽出エ
キス72gを得た。
[Preparation Example 9] Extraction of plants of the genus Walnut (Juglans) Nogueira (Juglans reg)
1 kg of the bark pulverized product of ia) was subjected to supercritical extraction to obtain 72 g of an extracted extract.

【0027】〔調製例10〕イワダレソウ(Lippi
a)属植物の抽出 エルヴァ・シドレイラ:Erva−cidreira
(Lippia alba)、アレクリン・ピメンタ:
Alecrim−pimenta(L.alnifol
ia)、アレクリン・ダ・チャパダ:Alecrim−
da−chapada(L.gracilis)、アレ
クリン・ド・カンポ:Alecrim−do−camp
o(L.microphylla)、カピトン・ド・マ
ット:Capitao−do−mato(L.pseu
do−thea)とエストレパ・カヴァロ:Estre
pa−cavalo(L.sidoides)の、それ
ぞれ根の粉砕物1kgに10Lの95%エタノールを加
え、室温で2日間抽出した。抽出液を濾過した後、エタ
ノールを減圧留去して、抽出エキス80g、104g、
89g、110g、95g、81gを得た。
[Preparation Example 10]
a) Extraction of genus plants Erva-cidreira: Erva-cidreira
(Lippia alba), Alecrin Pimenta:
Alecrim-pimenta (L. alnifol
ia), Alecrin da Chapada: Alecrim-
da-chapada (L. gracilis), Alecrim-do-campo: Alecrim-do-camp
o (L. microphylla), Capitan de Matt: Capitao-do-mat (L. pseudo
do-thea) and Estrepa Cavallo: Estre
10 L of 95% ethanol was added to 1 kg of each pulverized root of pa-cavalo (L. sideoids) and extracted at room temperature for 2 days. After the extract was filtered, ethanol was distilled off under reduced pressure, and 80 g, 104 g of the extracted extract,
89 g, 110 g, 95 g and 81 g were obtained.

【0028】〔実験例1〕調整例に従って得た各植物の
抽出エキスを用い、下記の方法で生体組織に傷害を与え
る一重項酸素の消去能について評価した。結果を表1に
示す。方法:一重項酸素はローズベンガル(和光純薬工
業(株))に蛍光灯を照射することにより発生させ、ス
クワレンの酸化の程度を指標に一重項酸素消去能を測定
した。3mMスクワレン、25μMローズベンガルにな
るようにサンプルの適量とメタノールを加えて溶液を調
製した。コントロールにはメタノールのみを加えた。4
℃で蛍光灯を18時間照射した。照射時間0時間のもの
をブランクとした。生じた過酸化スクワレンをTBA法
にて定量した。標準物質には1,1,3,3−テトラエ
トキシプロパン(和光純薬工業(株))を用いた。1m
lの溶液にTBA試薬(0.375%チオバルビトール
酸、15%トリクロロ酢酸、0.04%ブチルヒドロキ
シトルエン、2%エタノール、0.25N塩酸)を2m
l加えて、撹拌後、沸騰水浴上で1時間加熱した。氷冷
して室温まで冷却後、ブタノールで抽出し、ブランクを
対照として535nmの吸光度を測定した。一重項酸素
消去能の程度は、コントロールのTBA値を100とし
たときの相対値で表わし、90%以上を◎、60〜89
%を○、30〜59%を△、30%未満を×として表わ
した。
[Experimental Example 1] Using the extract of each plant obtained according to the Preparation Example, the following method was used to evaluate the ability to scavenge singlet oxygen that damages living tissues. Table 1 shows the results. Method: Singlet oxygen was generated by irradiating Rose Bengal (Wako Pure Chemical Industries, Ltd.) with a fluorescent lamp, and the singlet oxygen scavenging ability was measured using the degree of oxidation of squalene as an index. A solution was prepared by adding an appropriate amount of the sample and methanol so as to obtain 3 mM squalene and 25 μM rose bengal. Control only received methanol. 4
Irradiated with fluorescent light at 18 ° C. for 18 hours. A blank with an irradiation time of 0 hours was used as a blank. The resulting squalene peroxide was quantified by the TBA method. 1,1,3,3-tetraethoxypropane (Wako Pure Chemical Industries, Ltd.) was used as a standard substance. 1m
2 ml of TBA reagent (0.375% thiobarbitolic acid, 15% trichloroacetic acid, 0.04% butylhydroxytoluene, 2% ethanol, 0.25N hydrochloric acid)
After stirring, the mixture was heated on a boiling water bath for 1 hour. After cooling with ice and cooling to room temperature, the mixture was extracted with butanol, and the absorbance at 535 nm was measured using a blank as a control. The degree of singlet oxygen scavenging ability is represented by a relative value when the TBA value of the control is set to 100, and 90% or more is represented by ◎, 60 to 89.
% Is represented by ○, 30 to 59% by Δ, and less than 30% by X.

【0029】[0029]

【表1】 [Table 1]

【0030】表1の結果から明らかなように、各植物抽
出物の高い一重項酸素消去能が立証された。
As is clear from the results in Table 1, the high singlet oxygen scavenging ability of each plant extract was proved.

【0031】〔実験例2〕調製例に従って得た各植物の
抽出エキスを用い、下記の方法で炎症やアレルギーの発
症に関与するヒアルロニダーゼの阻害活性について評価
した。結果を表2に示す。 方法:酵素(type IV−S from Bovi
ne testis、SIGMA社製)溶液100μl
(4,000unit/ml)に上記製造例で得た各抽
出エキス試料200μlを加えて、37℃で20分間イ
ンキュベートした。次に、酵素活性化剤(Compou
nd 48/80、SIGMA社製)溶液(0.1mg
/ml)200μlを加え、37℃で20分間インキュ
ベートした後、基質であるヒアルロン酸カリウム(fr
om rooster comb、和光純薬社製)溶液
(0.4mg/ml)500μlを入れ、37℃で40
分間インキュベートした。
[Experimental Example 2] Using the extract of each plant obtained according to the Preparation Example, the inhibitory activity of hyaluronidase involved in the development of inflammation and allergy was evaluated by the following method. Table 2 shows the results. Method: Enzyme (type IV-S from Bovi)
ne testis, SIGMA) 100 μl solution
(4,000 units / ml), 200 μl of each extract extract sample obtained in the above Preparation Example was added, and incubated at 37 ° C. for 20 minutes. Next, an enzyme activator (Compou)
nd 48/80, manufactured by SIGMA) solution (0.1 mg
/ Ml) and incubated at 37 ° C. for 20 minutes, followed by potassium hyaluronate (fr) as a substrate.
om rooster comb, Wako Pure Chemical Industries, Ltd.) solution (0.4 mg / ml) at 37 ° C.
Incubated for minutes.

【0032】次いで、0.4M水酸化ナトリウム溶液2
00μlを加えて反応を停止させた後、Morgan−
Elson法の変法(J.Biol.Chem.,21
7,959(1955))で生成したN−アセチルヘキ
ソサミン量を吸光度OD585n mから求めた。
Then, a 0.4 M sodium hydroxide solution 2
After adding 00 μl to stop the reaction, Morgan-
A modified version of the Elson method (J. Biol. Chem., 21
7,959 (1955)) and the resulting N- acetylhexosamine weight was determined from the absorbance OD 585n m in.

【0033】また、酵素反応には0.1mM酢酸緩衝液
(pH3.5)を用い、ヒアルロニダーゼ阻害活性は次
式より求められる阻害率で算出した。
In addition, a 0.1 mM acetate buffer (pH 3.5) was used for the enzyme reaction, and the hyaluronidase inhibitory activity was calculated by the inhibition rate determined by the following equation.

【0034】[0034]

【数1】 阻害率が90%以上を◎、60〜89%を○、30〜5
9%を△、30%未満を×として表わした。
(Equation 1) ◎, 90-90% or more, ○, 30-5
9% was represented by Δ, and less than 30% was represented by ×.

【0035】[0035]

【表2】 [Table 2]

【0036】表2の結果から明らかなように、各植物抽
出物の高いヒアルロニダーゼ阻害活性が立証された。
As is clear from the results in Table 2, the high hyaluronidase inhibitory activity of each plant extract was proved.

【0037】〔実験例3〕調製例に従って得た各植物の
抽出エキスを用い、下記の方法で組織の賦活化に関与し
ているコラーゲン合成能について評価した。結果を表3
に示す。 方法:24穴細胞培養用プレートにヒト皮膚由来線維芽
細胞(クラボウ社)を25%コンフレントになるように
播種し、コンフレントになるまで10%ウシ胎児血清を
含むDMEM培地で37℃、5%炭酸ガス存在下で培養
した。サンプルを適量加えた後、18時間同条件にて培
養した。コントロールには同量の培地を加えた。培養上
清中に含まれるI型コラーゲンをELISA法にて定量
した。100μlの培養上清をELISA用プレートに
添加し、18時間室温中で保管した。0.05%Twe
en−20を含むPBS(PBS−T)で洗浄後、1%
スキムミルク/PBS−Tで2時間ブロッキングした。
抗ヒトI型コラーゲン抗体、ペルオキシダーゼ標識抗ラ
ットIgG抗体で処理し、ペルオキシダーゼ発色用キッ
トを用いて発色させた。450nmの吸光度から培養上
清中に含まれるI型コラーゲン量を求めた。コントロー
ルに対して、I型コラーゲン量が120%以上を◎、1
01〜119%を○、100%未満を×として表わし
た。
EXPERIMENTAL EXAMPLE 3 Using the extract of each plant obtained according to the Preparation Example, the ability to synthesize collagen involved in tissue activation was evaluated by the following method. Table 3 shows the results
Shown in Method: Human skin-derived fibroblasts (Kurabo Co., Ltd.) were seeded on a 24-well cell culture plate so as to have a confluence of 25%. Until confluent, 37 ° C., 5% carbon dioxide in a DMEM medium containing 10% fetal bovine serum. Culture was performed in the presence of gas. After adding an appropriate amount of the sample, it was cultured under the same conditions for 18 hours. Controls received the same volume of medium. Type I collagen contained in the culture supernatant was quantified by ELISA. 100 μl of the culture supernatant was added to the ELISA plate and stored at room temperature for 18 hours. 0.05% Twe
After washing with PBS containing en-20 (PBS-T), 1%
Block with skim milk / PBS-T for 2 hours.
The cells were treated with an anti-human type I collagen antibody and a peroxidase-labeled anti-rat IgG antibody, and developed using a peroxidase coloring kit. The amount of type I collagen contained in the culture supernatant was determined from the absorbance at 450 nm. When the amount of type I collagen is 120% or more, ◎ 1
01 to 119% were represented by ○, and less than 100% were represented by x.

【0038】[0038]

【表3】 [Table 3]

【0039】表3の結果から明らかなように、各植物抽
出物の高いコラーゲン合成能が立証された。
As apparent from the results in Table 3, the high collagen synthesis ability of each plant extract was proved.

【0040】以下、本発明の外用組成物を配合した実施
例を示す。下記の例は、いずれも皮膚や毛髪、口腔のト
ラブルの予防・改善効果に優れており、安全性も良好な
ものであった。なお、各植物抽出物は調製例1〜10の
方法の抽出法によるものである。
Hereinafter, Examples in which the composition for external use of the present invention is blended will be described. The following examples were all excellent in the effects of preventing and improving skin, hair and oral troubles, and also excellent in safety. In addition, each plant extract is based on the extraction method of the method of Preparation Examples 1-10.

【0041】[0041]

【表4】 [Table 4]

【0042】[0042]

【表5】 [Table 5]

【0043】[0043]

【表6】 [Table 6]

【0044】[0044]

【表7】 [Table 7]

【0045】[0045]

【表8】 [Table 8]

【0046】[0046]

【表9】 [Table 9]

【0047】[0047]

【表10】 [Table 10]

【0048】[0048]

【表11】 *1 ライオン化学製 XM−503LN *2 三菱油化社製 ユカフォーマーAM75201[Table 11] * 1 Lion Chemical XM-503LN * 2 Mitsubishi Yuka Yuka Former AM75201

【0049】[0049]

【表12】 [Table 12]

【0050】[0050]

【表13】 [Table 13]

【0051】[0051]

【表14】 [Table 14]

【0052】[0052]

【表15】 [Table 15]

【0053】[0053]

【表16】 [Table 16]

【0054】[0054]

【表17】 [Table 17]

【0055】[0055]

【表18】 [Table 18]

【0056】[0056]

【表19】 [Table 19]

【0057】[0057]

【表20】 [Table 20]

【0058】[0058]

【表21】 ペースト状になるまでニーダで混合し、貼付剤組成物と
した。貼付剤組成物を不織布上に150g/cm2にな
るまで均一塗布し、ポリエチレンフィルムを施し、貼付
剤を調製した。
[Table 21] The mixture was mixed with a kneader until a paste was formed to give a patch composition. The patch composition was uniformly applied on the nonwoven fabric until the pressure became 150 g / cm 2 , and a polyethylene film was applied to prepare a patch.

【0059】[0059]

【表22】 [Table 22]

【0060】[0060]

【表23】 [Table 23]

【0061】[0061]

【表24】 [Table 24]

【0062】[0062]

【表25】 *1 信越化学工業(株) メトロース 65SH−1
500 *2 ライオン化学製 XM−503LN又はレオガー
ドGP又はUCC社製ポリマーJR400
[Table 25] * 1 Shin-Etsu Chemical Co., Ltd. Metroose 65SH-1
500 * 2 Lion Chemical XM-503LN or Leogard GP or UCC Polymer JR400

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/075 A61K 7/075 7/08 7/08 7/26 7/26 7/32 7/32 7/50 7/50 9/70 401 9/70 401 35/78 35/78 C W A61P 17/00 A61P 17/00 43/00 111 43/00 111 Fターム(参考) 4C076 AA12 AA16 BB31 CC18 CC20 DD28 DD30 DD34 DD37 DD38 DD46 DD50 DD51 DD59 DD60 EE09 EE23 4C083 AA111 AA112 AA122 AB032 AB052 AB172 AB222 AB442 AC012 AC022 AC072 AC102 AC122 AC212 AC242 AC302 AC312 AC342 AC352 AC422 AC432 AC442 AC472 AC482 AC532 AC542 AC582 AC642 AC662 AC742 AC782 AC812 AC852 AC862 AC902 AC912 AD092 AD132 AD162 AD172 AD282 AD352 AD532 AD572 AD662 CC02 CC04 CC05 CC17 CC23 CC37 CC38 CC39 CC41 CC42 DD08 DD11 DD23 DD27 DD31 EE13 EE14 EE16 EE21 EE22 EE32 EE33 EE35 4C088 AB12 AC03 AC04 AC05 AC06 BA08 NA06 ZA90 ZB35 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/075 A61K 7/075 7/08 7/08 7/26 7/26 7/32 7/32 7 / 50 7/50 9/70 401 9/70 401 35/78 35/78 C W A61P 17/00 A61P 17/00 43/00 111 43/00 111 F term (reference) 4C076 AA12 AA16 BB31 CC18 CC20 DD28 DD30 DD34 DD37 DD38 DD46 DD50 DD51 DD59 DD60 EE09 EE23 4C083 AA111 AA112 AA122 AB032 AB052 AB172 AB222 AB442 AC012 AC022 AC072 AC102 AC122 AC212 AC242 AC302 AC312 AC342 AC352 AC422 AC432 AC442 AC472 AC482 AC532 AC542 AC582 AC642 AC662 AC162 AD172 AD282 AD352 AD532 AD572 AD662 CC02 CC04 CC05 CC17 CC23 CC37 CC38 CC39 CC41 CC42 DD08 DD11 DD23 DD27 DD31 EE13 EE14 EE16 EE21 EE22 EE32 EE33 EE35 4C088 AB12 AC03 AC04 AC05 AC06 BA08 NA06 ZA90 ZB35

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 キシロピア(Xylopia)属植物、
バターナットノキ(Caryocar)属植物、グアズ
マ(Guazuma)属植物、タバコソウ(Cuphe
a)属植物、ヘテロプテリス(Heteropteri
s)属植物、スキアドテニア(Sciadoteni
a)属植物、アンペロジジフス(Ampelozizy
phus)属植物、ルエヘア(Luehea)属植物、
クルミ(Juglans)属植物及びイワダレソウ(L
ippia)属植物からなる群より選ばれた植物又はそ
れらの抽出物の一種又は二種以上を含有する外用組成
物。
1. A plant of the genus Xylopia,
Butternut (Caryocar) genus plant, Guazuma (Guazuma) genus plant, tobacco plant (Cuphe)
a) Genus plant, Heteropteri
s) Genus plant, Sciadoteni
a) A genus plant, Ampelodizis
phus), Luhea,
Walnut (Juglans) genus plant and Iwadareso (L
An external composition containing one or more plants selected from the group consisting of ipsia) plants or extracts thereof.
JP23797199A 1999-08-25 1999-08-25 Composition for external use Pending JP2001064145A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23797199A JP2001064145A (en) 1999-08-25 1999-08-25 Composition for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23797199A JP2001064145A (en) 1999-08-25 1999-08-25 Composition for external use

Publications (1)

Publication Number Publication Date
JP2001064145A true JP2001064145A (en) 2001-03-13

Family

ID=17023194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23797199A Pending JP2001064145A (en) 1999-08-25 1999-08-25 Composition for external use

Country Status (1)

Country Link
JP (1) JP2001064145A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001220320A (en) * 2000-02-09 2001-08-14 Mandom Corp Hair-growing agent composition
ES2179791A1 (en) * 2001-07-10 2003-01-16 Valefarma S L Cosmetic based on vegetable gum for topic application consists of material incorporating gel, emulsion and foaming surfactant containing additives
JP2003201214A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor
WO2004048358A1 (en) * 2002-11-22 2004-06-10 Nature's Sunshine Products, Inc. Control of cancer with annonaceous extracts
JP2012036128A (en) * 2010-08-06 2012-02-23 Oriza Yuka Kk Collagen production promoter and skin-beautifying composition comprising the same
FR2964321A1 (en) * 2010-09-06 2012-03-09 Peaux Cibles Use of Xylopia aethiopica, as an antagonist of alpha 2-adrenergic receptors in adipose, alone or in combination with at least one other alpha-2-blocker for the preparation of a slimming composition and cosmetic composition

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001220320A (en) * 2000-02-09 2001-08-14 Mandom Corp Hair-growing agent composition
ES2179791A1 (en) * 2001-07-10 2003-01-16 Valefarma S L Cosmetic based on vegetable gum for topic application consists of material incorporating gel, emulsion and foaming surfactant containing additives
JP2003201214A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor
WO2004048358A1 (en) * 2002-11-22 2004-06-10 Nature's Sunshine Products, Inc. Control of cancer with annonaceous extracts
GB2408932A (en) * 2002-11-22 2005-06-15 Nature S Sunshine Products Inc Control of cancer with annonaceous extracts
JP2012036128A (en) * 2010-08-06 2012-02-23 Oriza Yuka Kk Collagen production promoter and skin-beautifying composition comprising the same
FR2964321A1 (en) * 2010-09-06 2012-03-09 Peaux Cibles Use of Xylopia aethiopica, as an antagonist of alpha 2-adrenergic receptors in adipose, alone or in combination with at least one other alpha-2-blocker for the preparation of a slimming composition and cosmetic composition

Similar Documents

Publication Publication Date Title
DK2606874T3 (en) Novel cosmetic and / or pharmaceutical compositions and their use / novel cosmetic and / or pharmaceutical Compositions and uses thereof
JP2004524335A (en) Compositions containing feverfew extract and methods of using same
EP1549331B2 (en) Use of purslane to treat facial wrinkles
JP2000169383A (en) Antiallergic agent
JP2005187474A (en) Improved scented cosmetic
JPH0853360A (en) Histamine liberation inhibitor and cosmetic and food product containing the same
JP2001335499A (en) Cosmetic composition
JP3784962B2 (en) Hair growth inhibitor
KR101780836B1 (en) 3,5-dihydroxy-2-menthenyl stilbene, plant extract containing same, method for collecting same, and application for same
JP6154567B2 (en) Moisturizer, method for producing the same, and cosmetic comprising the moisturizer
WO2012014901A1 (en) Carbonylation inhibitor
JP2016145197A (en) Deodorant
JP2001064145A (en) Composition for external use
JP2001122763A (en) Composition for external use
US20130028849A1 (en) Agent For Stimulating The Expression of Loxl
JP2001151634A (en) Composition for external use
JP2000256171A (en) Cosmetic composition
JP2004026743A (en) Polylysine preparation and cosmetic composition containing the same
JP4247091B2 (en) Skin anti-aging agent
JP5366358B2 (en) Agent for acting on skin aging mechanism, anti-aging skin external preparation, and anti-aging method
JPH03112912A (en) Cosmetic composition
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JP2002284648A (en) Composition for hair restorer
JP5155543B2 (en) Endothelin-1 production inhibitor, hexosaminidase release inhibitor, anti-inflammatory / whitening skin preparation, endothelin-1 production inhibition method, and hexosaminidase release inhibition method
JP2021113172A (en) Peptidyl arginine deiminase 1 expression promoter